Comparison of Cumulative Opioid Consumption Between Variable-Rate Feedback Infusion and Fixed-Rate Basal Infusion Modes of Intravenous PCA Following Mixed Surgery
Prospective Randomized Controlled Study of Individualized PCA Model Based on Multi-dimensional Strategies (Cumulative Opioid Consumption Between Variable-Rate Feedback Infusion and Fixed-Rate Basal Infusion Modes)
1 other identifier
interventional
426
1 country
1
Brief Summary
Perioperative pain management affects patient recovery. However, the rate of moderate to severe postoperative pain is as high as 73.8%, which hinders recovery and increases the risk of complications. Although opioids are the first-line analgesics, excessive use leads to adverse reactions. The traditional fixed-rate PCA mode is difficult to match the changes in postoperative pain. This study will compare different PCA mode optimization strategies, assuming that they can reduce opioid dosage, improve analgesic effect, and reduce adverse reactions, providing high-quality evidence-based basis for postoperative analgesia and promoting individualized and intelligent management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable surgery
Started Dec 2025
Shorter than P25 for not_applicable surgery
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2025
CompletedStudy Start
First participant enrolled
December 30, 2025
CompletedFirst Posted
Study publicly available on registry
January 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
February 11, 2026
January 1, 2026
10 months
December 22, 2025
February 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Cumulative opioid consumption
Within the first 24 hours postoperatively
Secondary Outcomes (9)
Resting and movement pain score was assessed by NRS
At 1, 6, 12, 24, and 48 hours postoperatively
Cumulative PCA volume consumption
Within the first 24 hours postoperatively
Frequency of additional rescue analgesics
At 12, 24, and 48 hours postoperatively
Dosage of additional rescue analgesics
At 12, 24, and 48 hours postoperatively
Postoperative quality of recovery
At 24, and 48 hours postoperatively
- +4 more secondary outcomes
Study Arms (2)
Fixed-rate basal infusion mode group
ACTIVE COMPARATORVariable-rate feedback infusion mode group
EXPERIMENTALInterventions
All participants received a standardized PCA solution containing sufentanil (100 μg), ondansetron (16 mg), and normal saline with total volume 100 mL. In conventional fixed-rate basal infusion mode group, the PCA was set to administer a bolus of 2 mL with a lock out interval of 15 minutes and background infusion rate 2 mL/h.
All participants received a standardized PCA solution containing sufentanil (100 μg), ondansetron (16 mg), and normal saline with total volume 100 mL. In variable-rate feedback infusion mode group, a bolus of 2 mL with a lock out interval of 15 minutes and background infusion rate 2 mL/h, which increased to 2.5 mL/h, was used whenever the demand dose was administered within lock out interval. The background infusion rate automatically decreased by 0.5 mL/h when the bolus button was not pressed for 1 hour. The background infusion rate was limited to a maximum of 12.0 mL/h and a minimum of 1 mL/h. The specific variable-rate feedback infusion mode setting was based on previous research, and the opinions of manufacturers and researchers to ensure patient safety and to provide effective analgesia.
Eligibility Criteria
You may qualify if:
- aged between 18 to 65 years;
- American Society of Anesthesiologists physical status Ⅰ - Ⅲ;
- Patients scheduled for elective mixed surgery were enrolled. Mixed surgeries included thoracoscopic surgery, laparoscopic surgery, hysteroscopy surgery, laparotomy, thoracotomy, open spinal surgery, craniotomy, and so on.
You may not qualify if:
- Allergy to PCA medications;
- Presence of chronic pain syndromes;
- Presence of psychiatric disorders, or severe cardiovascular, cerebrovascular, renal, or hepatic dysfunction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Second Affiliated Hospital of Hainan Medical Universitycollaborator
- Beijing Tiantan Hospitallead
- Shenzhen University General Hospitalcollaborator
- Youjiang Medical College for Nationalitiescollaborator
- The Peoples' Hospital of Jiaozuo Citycollaborator
Study Sites (1)
Beijing Tiantan Hospital, Beijing, Beijing 100070
Beijing, China
Related Links
- Mitra S, Carlyle D, Kodumudi G, Kodumudi V, Vadivelu N. New Advances in Acute Postoperative Pain Management. Curr Pain Headache Rep. 2018;22(5):35.
- Momeni M, Crucitti M, De Kock M. Patient-controlled analgesia in the management of postoperative pain. Drugs. 2006;66(18):2321-37.
- Jung KT, So KY, Kim SU, Kim SH. The Optimizing Background Infusion Mode Decreases Intravenous Patient-Controlled Analgesic Volume and Opioid Consumption Compared to Fixed-Rate Background Infusion in Patients Undergoing Laparoscopic Cholecystectomy: A Pro
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Department of Pain Management, Principal Investigator, Clinical Professor
Study Record Dates
First Submitted
December 22, 2025
First Posted
January 23, 2026
Study Start
December 30, 2025
Primary Completion (Estimated)
October 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
February 11, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures and appendices) are available. Derived data supporting the findings of this study are available from the corresponding author Fang Luo on request.